Elizabeth Greetham

Greetham previously was CEO and CFO of DrugAbuse Sciences and a portfolio manager at Weiss, Peck & Greer. Also is a director of King Pharmaceuticals Inc.

  • 2007 First Quarter

Added to: Ligand Pharmaceuticals Inc. - La Jolla, CA

Ligand is a drug development company. Revenues are $34 million.